高カリウム血症（Hyperkalemia）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hyperkalemia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Hyperkalemia to Metabolic Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Hyperkalemia 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Hyperkalemia Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Hyperkalemia 29
Mar 25, 2014: ZS Pharma Announces Start of Enrollment of Phase 3 Extended Dosing Study of ZS-9 in Patients with Hyperkalemia 29
Feb 04, 2014: Relypsa Completes Enrollment of Phase 1 Onset-of-Action Study for Patiromer 29
Jan 13, 2014: ZS Pharma Announces Positive Results From the Extended Treatment Phase of Its Phase 3 Trial of ZS-9 in Patients With Hyperkalemia 30
Jan 13, 2014: Relypsa Provides Corporate Update 31
Nov 09, 2013: ZS Pharma Announces Positive Top-Line Results of Phase 3 Trial of ZS-9 in Patients with Hyperkalemia 32
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
ZS Pharma, Inc. 34
Clinical Trial Overview of ZS Pharma, Inc. 34
Relypsa, Inc. 35
Clinical Trial Overview of Relypsa, Inc. 35
Clinical Trial Overview of Top Institutes / Government 36
Shonankamakura General Hospital 36
Clinical Trial Overview of Shonankamakura General Hospital 36
South Asian Clinical Toxicology Research collaboration 37
Clinical Trial Overview of South Asian Clinical Toxicology Research collaboration 37
Dalian Medical University 38
Clinical Trial Overview of Dalian Medical University 38
Maisonneuve-Rosemont Hospital 39
Clinical Trial Overview of Maisonneuve-Rosemont Hospital 39
The University of Texas Health Science Center at San Antonio 40
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 40
Medical University of Vienna 41
Clinical Trial Overview of Medical University of Vienna 41
Hadassah Medical Organization 42
Clinical Trial Overview of Hadassah Medical Organization 42
Five Key Clinical Profiles 43
Appendix 110
Abbreviations 110
Definitions 110
Research Methodology 111
Secondary Research 111
About GlobalData 112
Contact Us 112
Disclaimer 112
Source 112